Quick links

  • Our services
  • Insights & Resources
  • Latest news
  • Contact us
Cancel
  • Company
  • Careers
  • FAQ
  • Contact Us
  • Company
  • Careers
  • FAQ
  • Contact Us
  • Services
    • Containers Closure Integrity (CCI)
    • Analytical testing
    • Siliconization, testing and analysis
    • Primary container & device selection and evaluation
    • Drug combination product design verification
    • Small-scale fill finish & assembly
    • Product complaint management and root cause investigation
    • Combination product incoming-to-lot release testing
    • Additional services
    menu imagemenu imagemenu image
  • Combination Product Expertise
    • Concept to Commercialization
    • Testing Advisory
    • Testing Standards
    • Design control advisory
    • Novel technology development
    menu imagemenu imagemenu image
  • Insights & Resources
    • Investors
    • Webinars
    • Case Studies
    • Blog
    • Events
    • FAQ
    • Quality
    • Sustainability
    menu imagemenu imagemenu image
Request a Quote
  • Home

ZebraSci Announces Expansion to East Coast to Support Global Customer Base

October 24, 2018

By pace_developer

The new headquarters is just 45 minutes from New York City and located in the heart of the medical and pharma corridor of Central NJ.  Fortune 100s continue to thrive in this area, including Pfizer, Merck, JNJ, Janssen, Ethicon, and BMS among others. Additionally, all Tri-State, New England, and Mid Atlantic Pharma|MedTech organizations have easy access to … Continued

Recent Posts

  • Common considerations for packaging and shipping vaccines
  • ZebraSci Acheives ISO 13485 Certification
  • ZebraSci Launches Audible Device Testing Capabilities
  • ZebraSci Can Help Clients Avoid Costly Device Integration Challenges
  • Are you Changing your Silicone Lubricant?

Recent Comments

No comments to show.

Follow Us On

LinkedIn

BD, the BD logo, Libertas, Neopak, Physioject and Vystra are trademarks of Becton, Dickinson and Company or its affiliates. ZEBRASCI, Inc. Copyright © 2025 All Rights Reserved

  • Investor
  • Privacy
  • Cookie Preferences
  • Terms of Use